Nacre Capital

Nacre Capital

Global venture builder for deep-tech startups

Overview

Nacre Capital is a global venture builder that creates, builds, and grows disruptive start-ups based on deep technologies. It brings together entrepreneurs, scientists, technologists, researchers, and growth experts to imagine and develop ventures from scratch, guiding ideas from concept to fast-growing, market-leading companies. The team provides end-to-end support—identifying opportunities, building teams, securing resources, and scaling ventures—through an in-house portfolio that targets solutions to complex societal problems with breakthrough deep tech. Unlike typical investment firms, Nacre Capital combines hands-on venture creation with deep technical and domain expertise across an international network. Its goal is to transform novel ideas into world-class companies that deliver significant, lasting impact.

About Nacre Capital

Simplify's Rating
Why Nacre Capital is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Food & Agriculture

AI & Machine Learning

Biotechnology

Healthcare

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

Tel Aviv-Yafo, Israel

Founded

N/A

Get referred to Nacre Capital

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Aquaticode closed a $6 million Series A in August 2022 with Nacre participation.
  • Fairtility raised $15 million Series A in May 2022, validating Nacre’s healthtech thesis.
  • Nacre’s website lists FDNA, Fairtility, Seed-X, Aquaticode, CureSign, and Kinsame.

What critics are saying

  • Nacre Capital lacks visible 2025-2026 financing or hiring data, obscuring momentum.
  • Portfolio concentration in small deeptech bets ties outcomes to clinical, regulatory, and sales cycles.
  • If Fairtility, FDNA, or Seed-X stall, Nacre Capital loses its clearest credibility engine.

What makes Nacre Capital unique

  • Moti Shniberg built Face.com and CyberMDX, proving repeatable company creation.
  • Nacre Capital operates as a venture builder, not a passive fund, adding execution leverage.
  • Its portfolio targets deep-AI niches: fertility, rare disease, seeds, aquaculture, and cybersecurity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Company News

ApkaHindiBlog
Aug 30th, 2022
Aquaticode Closes USD6M Series A Funding » ApkaHindiBlog

AquaticodeIn its first round of external financing, 6M USD was raised by, a Stavanger-based technology developer that boosts global seafood production.

FinSMEs
May 24th, 2022
Fairtility Closes $15M Series A Funding

Fairtility, a Tel Aviv Israel-based transparent AI innovator powering in vitro fertilization (IVF), closed a $15 million Series A funding round. The round, which brings total funding to $18.5m to date, was led by Gurnet Point Capital, and included Nacre Capital and additional investors. The company intends to use the funds to advance clinical research with fertility clinics and academic [] The post Fairtility Closes $15M Series A Funding appeared first on FinSMEs.

Recently Posted Jobs

Sign up to get curated job recommendations

Nacre Capital is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →